Norway Blood-based Biomaker For Sports Medicine Market Size & Outlook
Norway blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Norway blood-based biomaker for sports medicine market highlights
- The Norway blood-based biomaker for sports medicine market generated a revenue of USD 5.2 million in 2023 and is expected to reach USD 7.6 million by 2030.
- The Norway market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 5.2 million |
| Market revenue in 2030 | USD 7.6 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Norway accounted for 0.8% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 17.31% in 2023. Horizon Databook has segmented the Norway blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In Norway, participation in organized youth sports is remarkably high, with a ScienceDirect report from September 2021 indicating that about 93% of teenagers aged 13 to 19 are or have been active members of sports clubs. This widespread involvement highlights the significant role that sports play in the lives of Norwegian youth and underscores the need for effective health management strategies.
As sports participation continues to rise, the market for blood-based biomarkers in sports medicine in Norway is expanding. These biomarkers are crucial for monitoring athlete health, preventing injuries, and optimizing performance. They offer valuable insights into an athlete’s physiological state, enabling more precise and personalized care.
The growing emphasis on advanced medical technologies is driven by the increasing number of athletes and the demand for improved injury management & performance enhancement.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Norway Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
